Vizsgálati helyszín
Policlinico San Donato S.p.A.
San Donato Milanese, 20097, OlaszországMég nincs intézményhez kötve
- 22futó vizsgálat
- 6lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 28 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis13 vizsgálat
- 2. fázis11 vizsgálat
- 2/3. fázis2 vizsgálat
- 4. fázis2 vizsgálat
- Állapot
- Toboroz16 vizsgálat
- Lezárult6 vizsgálat
- Fut, nem toboroz5 vizsgálat
- Még nem toboroz1 vizsgálat
- Fő szponzor
- Novo Nordisk A/S3 vizsgálat
- Eli Lilly & Co.2 vizsgálat
- Hoffmann-La Roche2 vizsgálat
- Sanofi-Aventis Recherche & Developpement2 vizsgálat
- Spyre Therapeutics, Inc.2 vizsgálat
- és még 17
Futó vizsgálatok
Toboroz
A trial to learn how safe elecoglipron is and how well it works in adults living with obesity or excess body weight with or without type 2 diabetes
2025-524688-19-00· 3. fázis· AstraZeneca AB· Forrás
Toboroz
A study of LY4268989 in participants with Moderately to Severely Active Ulcerative Colitis (EMERALD-3)
2025-524404-29-00· 2. fázis· Eli Lilly & Co.· Forrás
Meghívásos bevonás
Long-term Safety and Efficacy of Multiple Long-acting Antibodies Alone and in Combinations for IBD
NCT07652294· 2. fázis· Spyre Therapeutics, Inc.· Forrás
Toboroz
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
NCT07567001· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
Pharmacological optimization in prevention in Heart Failure: A Sex-gap?
2025-520660-18-00· 4. fázis· Policlinico San Donato S.p.A.· Forrás
Toboroz
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
NCT07509307· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
Long-term Efficacy and Safety Extension (LTE) Study of Barzolvolimab in Participants with Chronic Spontaneous Urticaria
2025-522878-36-00· 3. fázis· Celldex Therapeutics Inc.· Forrás
Toboroz
A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
NCT07481630· 3. fázis· Novo Nordisk A/S· Forrás
Toboroz
Confirmatory Clinical Study in Active Ulcerative Colitis
NCT07296315· 2. fázis· MRM Health NV· Forrás
Toboroz
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
NCT07351045· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
A randomized, double-blinded, placebo-controlled trial to evaluate the efficacy and safety of ninerafaxstat in patients with symptomatic non-obstructive hypertrophic cardiomyopathy
2024-515125-28-00· 2. fázis· Imbria Pharmaceuticals Inc.· Forrás
Toboroz
A Study of Orforglipron (LY3502970) on Cardiovascular Outcomes in Adults With Atherosclerotic Cardiovascular Disease and/or Chronic Kidney Disease (ATTAIN-Outcomes)
NCT07241390· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
NCT06979336· 2. fázis· Genentech, Inc.· Forrás
Toboroz
A Study of Long-acting Antibodies Alone and in Combinations for Moderate to Severe Ulcerative Colitis
NCT07012395· 2. fázis· Spyre Therapeutics, Inc.· Forrás
Toboroz
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (RO7790121) in Participants With Moderately to Severely Active Crohn's Disease
NCT06819891· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Trial on the Biological and Clinical Effects of Acetyl-L-carnitine in ALS
NCT06126315· 2/3. fázis· Mario Negri Institute for Pharmacological Research· Forrás
Toboroz
An Adaptive, Dose-Ranging, Phase 2 Study of Eltrekibart Given Alone or in Combination with Mirikizumab for the Treatment of Adult Patients with Moderately to Severely Active Ulcerative Colitis
2023-507853-13-00· 2. fázis· Eli Lilly & Co.· Forrás
Fut, nem toboroz
A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy
NCT06481891· 3. fázis· Lexicon Pharmaceuticals· Forrás
Fut, nem toboroz
A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU)
NCT06455202· 3. fázis· Celldex Therapeutics· Forrás
Toboroz
COLchicine and Thiamine in Heart Failure Due to Ischemic Heart Disease
NCT05873881· 3. fázis· Hamilton Health Sciences Corporation· Forrás
Toboroz
Single Antiplatelet Treatment With Ticagrelor or Aspirin After Transcatheter Aortic Valve Implantation
NCT05283356· 4. fázis· Fundacin Biomedica Galicia Sur· Forrás
Meghívásos bevonás
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten in Adults With HCM
NCT04848506· 2/3. fázis· Cytokinetics· Forrás
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Hibát jelzek